📌 Key Takeaways
- Topic: What Is Pyrogenic Silica? How It Is Made and Why It Is Used as a Thickener
- Keywords: silica excipient
- Published: 2026-11-20 05:19:11
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Ultrafine Silica Powder: Particle Sizes, Specifications and Applications
- Silica Tapped Density: Definition, Measurement and Typical Values
- What Is EMC Filler? Silica Fillers for Epoxy Molding Compounds Explained
- Aluminum Silicate vs Silica: Composition, Properties and Uses Compared
- Kim, K. S. et al. Adsorbate-dependent uptake behavior of topographically bi-functionalized ordered mesoporous silica materials. J. Porours Mater. 22, 1297-1303 (2015). Post CAS Google Scholar
- Copper Clad Laminate Filler: Silica Types, Dielectric Properties and Selection
- Hao, Y.-N. et al. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy. J. Mater. Chem. B 9, 250-266 (2021). Piece CAS PubMed Google Scholar
Submicron Spherical Silica: Specifications and Uses in Underfill and Advanced Packaging
What is silica (SiO₂)?
silica supplier Japan Huang, C. et al. Robust nanovaccine based on polydopamine‐coated mesoporous silica nanoparticles for effective photothermal‐immunotherapy against melanoma. Adv. Funct. Mater. 31, 2010637 (2021). Article CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
rubber grade silica Pearce, A. K. & O'Reilly, R. K. Insights into active targeting of nanoparticles in drug delivery: Advances in clinical studies and design considerations for cancer nanomedicine. Bioconjugate Chem. 30, 2300-2311 (2019). Article CAS Google Scholar
What drives silica raw material prices?
silica matting agent MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.